Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-02

Clinical Trial Update: A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.

View source ↗

Summary

This clinical trial update compares the efficacy and safety of telitacicept versus belimumab for systemic lupus erythematosus, based on prior data, in a multi-u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Belimumab (belimumab)
  • Telitacicept

Snippet

Sponsor: Yipeng Liu | Conditions: Systemic Lupus Erythematosus, Telitacicept | Status: ACTIVE_NOT_RECRUITING